Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Alireza Sepehri Shamloo"'
Autor:
Ulrich Halm, Regina Lamberts, Andreas Schubert-Hartmann, Alireza Sepehri-Shamloo, Markus Zachäus, Andreas Flade, Michael Bartels
Publikováno v:
Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie. 148:140-146
Zusammenfassung Hintergrund Die Standardtherapie der akuten Cholezystitis ist die laparoskopische Cholezystektomie. Bei Patienten mit hohem Operationsrisiko kommen alternative Verfahren zur Anwendung. Die perkutane Drainage ist allgemein verfügbar.
Autor:
M. Kobel, Frank-Thomas Riede, P Kalden, Anna Michaelis, Alireza Sepehri Shamloo, Franziska Markel, S Mensch, Christian Paech, Roman Gebauer, Ingo Dähnert, F. Löffelbein, Michael Weidenbach, Andreas Bollmann
Publikováno v:
Pediatric Cardiology. 43:191-196
The development of smart technologies paves the way for new diagnostic modalities. The Apple Watch provides an FDA approved iECG function for users from 22 years of age. Yet, there are currently no data on the accuracy of the Apple Watch iECG in chil
Publikováno v:
Herz. 46:336-341
With a growing acceptance of clinical hypnosis in medicine, new fields of application are being explored. Data from recent studies support the use of hypnosis for pain management during procedures, such as ablation of arrhythmias and implantation of
Autor:
Andreas Bollmann, Federica Torri, Arash Arya, Elena Efimova, Angeliki Darma, Gerhard Hindricks, Alireza Sepehri Shamloo, Borislav Dinov, Nikolaos Dagres, Daniela Husser-Bollmann, Livio Bertagnolli
Publikováno v:
Herzschrittmachertherapie & Elektrophysiologie
Ablation of ventricular tachycardias (VTs) in patients with structural heart disease (SHD) has been associated with advanced heart failure and poor survival.This matched case-control study sought to assess the difference in survival after left ventri
Publikováno v:
Herz. 46:28-37
Die neuen Leitlinien zur Diagnose und Behandlung von Vorhofflimmern (VHF) wurden im August 2020 von der European Society of Cardiology (ESC) in Zusammenarbeit mit der European Association of Cardio-Thoracic Surgery (EACTS) veroffentlicht. Die Leitlin
Autor:
Gerhard Hindricks, Julia Lurz, Livio Bertagnolli, Arash Arya, Angeliki Darma, Andreas Bollmann, Alireza Sepehri Shamloo, Daniela Husser-Bollmann, Federica Torri, Nikolaos Dagres, Borislav Dinov
Publikováno v:
EP Europace. 22:1672-1679
AimsAblation of ventricular tachycardias (VTs) in patients with structural heart disease has been established in the past decades as an effective and safe treatment. However, the prognosis and long-term outcome remains poor.Methods and resultsWe inve
Publikováno v:
Clinical Research in Cardiology. 109:957-966
In clinical practice, atrial fibrillation (AF) is known as the most common sustained arrhythmia. Therefore, identification of individuals at risk of AF development/recurrence or its associated complications has emerged as a hot topic in the field of
Autor:
Andreas Bollmann, Livio Bertagnolli, Annina Stauber, Arash Arya, Andreas Müssigbrodt, Simon Kircher, B. Dinov, Alireza Sepehri Shamloo, Nikolas Dagres, Daniela Husser-Bollmann, Sergio Richter, Gerhard Hindricks
Publikováno v:
Heart, Lung and Circulation. 29:69-85
Introduction Atrial fibrillation (AF) has been recognised as the most prevalent sustained arrhythmia. Recently, a growing body of evidence has suggested that AF might be involved in the progression of cognitive impairment (CIM), potentially extending
Autor:
Sebastian Hilbert, Nikolaos Dagres, Alireza Sepehri Shamloo, Daniela Husser, Andreas Bollmann, Annina Stauber, Arash Arya, Angeliki Darma, Gerhard Hindricks, Andreas Müssigbrodt, Livio Bertagnolli, B. Dinov, Katharina Schoene
Publikováno v:
Heart Rhythm. 16:1492-1498
Background Although several investigations have shown a relationship between increased epicardial adipose tissue (EAT) and atrial fibrillation (AF), the association between EAT and ventricular tachycardia (VT) has not been evaluated. Objective We inv
Autor:
Nikolaos Dagres, Glen P. Martin, Zoher Kapacee, Xavier Jouven, Valentina Kutyifa, Serge Boveda, Juhani Junttila, Christian Sticherling, Katherine C. Wu, Rik Willems, Antti M. Kiviniemi, Frieder Braunschweig, Georg Schmidt, Jiri Jarkovsky, Jens Brock Johansen, Mahmoud Suleiman, Alireza Sepehri Shamloo, Artur Akbarov, Laura Fusini, Stephanie Ng, Christian de Chillou, Francisco Leyva, Dick L. Willems, Kevin Kris Warnakula Olesen, Radosław Lenarczyk, Andrea Manca, Youssef Taleb, Arthur A.M. Wilde, Eloi Marijon, Milos Taborsky, Jens Cosedis Nielsen, Niels Peek, Julie Pester, Markus Zabel, Gerhard Hindricks, Gordon F. Tomaselli, Petra Barthel, Chris P Gale, Nancy R. Cook, Golnoosh Motamedi-Ghahfarokhi, Jonas Faxén, Le Mai Parkes, Peter J. Schwartz, Michael Maeng, Christine M. Albert, Gianluca Pontone, Tim Friede, Enrico Longato, Jacob Tflt-Hansen, Manickavasagar Vinayagamoorthy, Daniel Lee, Jan G.P. Tijssen, Ursula Marschall, Tom E Verstraelen, Christopher A. Miller, Hanno L. Tan, Marcus Eng Hock Ong, Petra J. M. Elders, Jill Leigh, Daniel Sprague, Thomas Olsen
Publikováno v:
medRxiv
IntroductionSudden cardiac death (SCD) is the leading cause of death in patients with myocardial infarction (MI) and can be prevented by the implantable cardioverter defibrillator (ICD). Currently, risk stratification for SCD and decision on ICD impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2429dc925d9f253cc9eafc74d455cd52
https://doi.org/10.1101/2021.07.12.21260002
https://doi.org/10.1101/2021.07.12.21260002